パルボシクリブ錠剤の世界市場成長 2024-2030Global Palbociclib Tablets Market Growth 2024-2030 パルボシクリブ錠は、主に特定のタイプの乳がんの治療に使用される薬剤です。具体的には、ホルモン受容体陽性、HER2陰性の乳がんで、他の部位に転移していたり進行していたりする場合に、他の治療薬と組み合わせ... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーパルボシクリブ錠は、主に特定のタイプの乳がんの治療に使用される薬剤です。具体的には、ホルモン受容体陽性、HER2陰性の乳がんで、他の部位に転移していたり進行していたりする場合に、他の治療薬と組み合わせて使用される。パルボシクリブ錠剤の世界市場規模は、2024年の100万米ドルから2030年には100万米ドルに成長すると予測されており、2024年から2030年までの年平均成長率は%と予測されている。 LPインフォメーション社の最新リサーチレポート「パルボシクリブ錠(Palbociclib Tablets)の産業予測」は、過去の販売実績と2023年の世界全体のパルボシクリブ錠(Palbociclib Tablets)の販売実績を調査し、2024年から2030年までのパルボシクリブ錠(Palbociclib Tablets)の販売予測について地域別・市場分野別に包括的に分析しています。パルボシクリブ錠剤の売上高を地域別、市場分野別、サブセクター別に分類し、世界のパルボシクリブ錠剤産業の詳細な分析を百万米ドル単位で提供しています。 本インサイトレポートでは、世界のパルボシクリブ錠剤の状況を包括的に分析し、製品区分、企業形成、収益、市場シェア、最新動向、M&A活動などに関する主要動向を明らかにしています。また本レポートでは、パルボシクリブ錠のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要グローバル企業の戦略を分析し、加速する世界のパルボシクリブ錠市場におけるこれらの企業の独自の地位をより深く理解しています。 本インサイトレポートでは、パルボシクリブ錠の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの質的・量的市場インプットに基づいた透明性の高い手法により、本調査予測は世界のパルボシクリブ錠剤の現状と将来の軌道について非常にニュアンスのある見解を提供します。 Palbociclib Tabletsの米国市場は、2023年の100万米ドルから2030年には100万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。 Palbociclib Tabletsの中国市場は、2023年の100万米ドルから2030年には100万米ドルに、2024年から2030年までのCAGR %で増加すると推定される。 パルボシクリブ錠剤のヨーロッパ市場は、2023年の100万米ドルから2030年には100万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。 パルボシクリブ錠剤の世界的な主要企業は、ファイザー、CSPC Ouyi Pharmaceutical、Zydus Lifesciences、Synthon Pharmaceuticals、Sun Pharmaceuticalなどをカバーしています。売上高では、世界の2大企業が2023年にほぼ%のシェアを占めている。 のシェアを占めている。 本レポートでは、パルボシクリブ錠剤市場の製品タイプ、用途、主要メーカー、主要地域、国別の包括的な概要、市場シェア、成長機会を紹介する。 タイプ別セグメント 25mg/錠 75mg/錠 100mg/錠 125mg/錠 用途別セグメント 病院・クリニック 薬局 その他 本レポートでは、市場を地域別にも分割しています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、一次専門家から収集したインプットと、企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 ファイザー CSPC オウイ・ファーマシューティカル ザイダスライフサイエンス シンソン・ファーマシューティカルズ サン製薬 MSNファーマシューティカルズ 本レポートで扱う主な質問 世界のPalbociclib錠剤市場の10年見通しは? パルボシクリブ錠の世界市場および地域別市場成長の要因は何か? 市場別、地域別に最も急成長する技術は何か? パルボシクリブ錠の市場機会は最終市場規模によってどのように異なるのか? パルボシクリブ錠のタイプ別、用途別の内訳は? 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Palbociclib Tablets Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Palbociclib Tablets by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Palbociclib Tablets by Country/Region, 2019, 2023 & 2030 2.2 Palbociclib Tablets Segment by Type 2.2.1 25mg per Tablet 2.2.2 75mg per Tablet 2.2.3 100mg per Tablet 2.2.4 125mg per Tablet 2.3 Palbociclib Tablets Sales by Type 2.3.1 Global Palbociclib Tablets Sales Market Share by Type (2019-2024) 2.3.2 Global Palbociclib Tablets Revenue and Market Share by Type (2019-2024) 2.3.3 Global Palbociclib Tablets Sale Price by Type (2019-2024) 2.4 Palbociclib Tablets Segment by Application 2.4.1 Hospital and Clinic 2.4.2 Pharmacy 2.4.3 Other 2.5 Palbociclib Tablets Sales by Application 2.5.1 Global Palbociclib Tablets Sale Market Share by Application (2019-2024) 2.5.2 Global Palbociclib Tablets Revenue and Market Share by Application (2019-2024) 2.5.3 Global Palbociclib Tablets Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Palbociclib Tablets Breakdown Data by Company 3.1.1 Global Palbociclib Tablets Annual Sales by Company (2019-2024) 3.1.2 Global Palbociclib Tablets Sales Market Share by Company (2019-2024) 3.2 Global Palbociclib Tablets Annual Revenue by Company (2019-2024) 3.2.1 Global Palbociclib Tablets Revenue by Company (2019-2024) 3.2.2 Global Palbociclib Tablets Revenue Market Share by Company (2019-2024) 3.3 Global Palbociclib Tablets Sale Price by Company 3.4 Key Manufacturers Palbociclib Tablets Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Palbociclib Tablets Product Location Distribution 3.4.2 Players Palbociclib Tablets Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Palbociclib Tablets by Geographic Region 4.1 World Historic Palbociclib Tablets Market Size by Geographic Region (2019-2024) 4.1.1 Global Palbociclib Tablets Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Palbociclib Tablets Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Palbociclib Tablets Market Size by Country/Region (2019-2024) 4.2.1 Global Palbociclib Tablets Annual Sales by Country/Region (2019-2024) 4.2.2 Global Palbociclib Tablets Annual Revenue by Country/Region (2019-2024) 4.3 Americas Palbociclib Tablets Sales Growth 4.4 APAC Palbociclib Tablets Sales Growth 4.5 Europe Palbociclib Tablets Sales Growth 4.6 Middle East & Africa Palbociclib Tablets Sales Growth 5 Americas 5.1 Americas Palbociclib Tablets Sales by Country 5.1.1 Americas Palbociclib Tablets Sales by Country (2019-2024) 5.1.2 Americas Palbociclib Tablets Revenue by Country (2019-2024) 5.2 Americas Palbociclib Tablets Sales by Type (2019-2024) 5.3 Americas Palbociclib Tablets Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Palbociclib Tablets Sales by Region 6.1.1 APAC Palbociclib Tablets Sales by Region (2019-2024) 6.1.2 APAC Palbociclib Tablets Revenue by Region (2019-2024) 6.2 APAC Palbociclib Tablets Sales by Type (2019-2024) 6.3 APAC Palbociclib Tablets Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Palbociclib Tablets by Country 7.1.1 Europe Palbociclib Tablets Sales by Country (2019-2024) 7.1.2 Europe Palbociclib Tablets Revenue by Country (2019-2024) 7.2 Europe Palbociclib Tablets Sales by Type (2019-2024) 7.3 Europe Palbociclib Tablets Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Palbociclib Tablets by Country 8.1.1 Middle East & Africa Palbociclib Tablets Sales by Country (2019-2024) 8.1.2 Middle East & Africa Palbociclib Tablets Revenue by Country (2019-2024) 8.2 Middle East & Africa Palbociclib Tablets Sales by Type (2019-2024) 8.3 Middle East & Africa Palbociclib Tablets Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Palbociclib Tablets 10.3 Manufacturing Process Analysis of Palbociclib Tablets 10.4 Industry Chain Structure of Palbociclib Tablets 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Palbociclib Tablets Distributors 11.3 Palbociclib Tablets Customer 12 World Forecast Review for Palbociclib Tablets by Geographic Region 12.1 Global Palbociclib Tablets Market Size Forecast by Region 12.1.1 Global Palbociclib Tablets Forecast by Region (2025-2030) 12.1.2 Global Palbociclib Tablets Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Palbociclib Tablets Forecast by Type (2025-2030) 12.7 Global Palbociclib Tablets Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Pfizer 13.1.1 Pfizer Company Information 13.1.2 Pfizer Palbociclib Tablets Product Portfolios and Specifications 13.1.3 Pfizer Palbociclib Tablets Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Pfizer Main Business Overview 13.1.5 Pfizer Latest Developments 13.2 CSPC Ouyi Pharmaceutical 13.2.1 CSPC Ouyi Pharmaceutical Company Information 13.2.2 CSPC Ouyi Pharmaceutical Palbociclib Tablets Product Portfolios and Specifications 13.2.3 CSPC Ouyi Pharmaceutical Palbociclib Tablets Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 CSPC Ouyi Pharmaceutical Main Business Overview 13.2.5 CSPC Ouyi Pharmaceutical Latest Developments 13.3 Zydus Lifesciences 13.3.1 Zydus Lifesciences Company Information 13.3.2 Zydus Lifesciences Palbociclib Tablets Product Portfolios and Specifications 13.3.3 Zydus Lifesciences Palbociclib Tablets Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Zydus Lifesciences Main Business Overview 13.3.5 Zydus Lifesciences Latest Developments 13.4 Synthon Pharmaceuticals 13.4.1 Synthon Pharmaceuticals Company Information 13.4.2 Synthon Pharmaceuticals Palbociclib Tablets Product Portfolios and Specifications 13.4.3 Synthon Pharmaceuticals Palbociclib Tablets Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Synthon Pharmaceuticals Main Business Overview 13.4.5 Synthon Pharmaceuticals Latest Developments 13.5 Sun Pharmaceutical 13.5.1 Sun Pharmaceutical Company Information 13.5.2 Sun Pharmaceutical Palbociclib Tablets Product Portfolios and Specifications 13.5.3 Sun Pharmaceutical Palbociclib Tablets Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Sun Pharmaceutical Main Business Overview 13.5.5 Sun Pharmaceutical Latest Developments 13.6 MSN Pharmaceuticals 13.6.1 MSN Pharmaceuticals Company Information 13.6.2 MSN Pharmaceuticals Palbociclib Tablets Product Portfolios and Specifications 13.6.3 MSN Pharmaceuticals Palbociclib Tablets Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 MSN Pharmaceuticals Main Business Overview 13.6.5 MSN Pharmaceuticals Latest Developments 14 Research Findings and Conclusion
SummaryPalbociclib tablets are a medication used primarily in the treatment of certain types of breast cancer. Specifically, they are used in combination with other therapies for hormone receptor-positive, HER2-negative breast cancer that has spread to other parts of the body or is advanced. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Palbociclib Tablets Annual Sales 2019-2030 2.1.2 World Current & Future Analysis for Palbociclib Tablets by Geographic Region, 2019, 2023 & 2030 2.1.3 World Current & Future Analysis for Palbociclib Tablets by Country/Region, 2019, 2023 & 2030 2.2 Palbociclib Tablets Segment by Type 2.2.1 25mg per Tablet 2.2.2 75mg per Tablet 2.2.3 100mg per Tablet 2.2.4 125mg per Tablet 2.3 Palbociclib Tablets Sales by Type 2.3.1 Global Palbociclib Tablets Sales Market Share by Type (2019-2024) 2.3.2 Global Palbociclib Tablets Revenue and Market Share by Type (2019-2024) 2.3.3 Global Palbociclib Tablets Sale Price by Type (2019-2024) 2.4 Palbociclib Tablets Segment by Application 2.4.1 Hospital and Clinic 2.4.2 Pharmacy 2.4.3 Other 2.5 Palbociclib Tablets Sales by Application 2.5.1 Global Palbociclib Tablets Sale Market Share by Application (2019-2024) 2.5.2 Global Palbociclib Tablets Revenue and Market Share by Application (2019-2024) 2.5.3 Global Palbociclib Tablets Sale Price by Application (2019-2024) 3 Global by Company 3.1 Global Palbociclib Tablets Breakdown Data by Company 3.1.1 Global Palbociclib Tablets Annual Sales by Company (2019-2024) 3.1.2 Global Palbociclib Tablets Sales Market Share by Company (2019-2024) 3.2 Global Palbociclib Tablets Annual Revenue by Company (2019-2024) 3.2.1 Global Palbociclib Tablets Revenue by Company (2019-2024) 3.2.2 Global Palbociclib Tablets Revenue Market Share by Company (2019-2024) 3.3 Global Palbociclib Tablets Sale Price by Company 3.4 Key Manufacturers Palbociclib Tablets Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Palbociclib Tablets Product Location Distribution 3.4.2 Players Palbociclib Tablets Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Palbociclib Tablets by Geographic Region 4.1 World Historic Palbociclib Tablets Market Size by Geographic Region (2019-2024) 4.1.1 Global Palbociclib Tablets Annual Sales by Geographic Region (2019-2024) 4.1.2 Global Palbociclib Tablets Annual Revenue by Geographic Region (2019-2024) 4.2 World Historic Palbociclib Tablets Market Size by Country/Region (2019-2024) 4.2.1 Global Palbociclib Tablets Annual Sales by Country/Region (2019-2024) 4.2.2 Global Palbociclib Tablets Annual Revenue by Country/Region (2019-2024) 4.3 Americas Palbociclib Tablets Sales Growth 4.4 APAC Palbociclib Tablets Sales Growth 4.5 Europe Palbociclib Tablets Sales Growth 4.6 Middle East & Africa Palbociclib Tablets Sales Growth 5 Americas 5.1 Americas Palbociclib Tablets Sales by Country 5.1.1 Americas Palbociclib Tablets Sales by Country (2019-2024) 5.1.2 Americas Palbociclib Tablets Revenue by Country (2019-2024) 5.2 Americas Palbociclib Tablets Sales by Type (2019-2024) 5.3 Americas Palbociclib Tablets Sales by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Palbociclib Tablets Sales by Region 6.1.1 APAC Palbociclib Tablets Sales by Region (2019-2024) 6.1.2 APAC Palbociclib Tablets Revenue by Region (2019-2024) 6.2 APAC Palbociclib Tablets Sales by Type (2019-2024) 6.3 APAC Palbociclib Tablets Sales by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Palbociclib Tablets by Country 7.1.1 Europe Palbociclib Tablets Sales by Country (2019-2024) 7.1.2 Europe Palbociclib Tablets Revenue by Country (2019-2024) 7.2 Europe Palbociclib Tablets Sales by Type (2019-2024) 7.3 Europe Palbociclib Tablets Sales by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Palbociclib Tablets by Country 8.1.1 Middle East & Africa Palbociclib Tablets Sales by Country (2019-2024) 8.1.2 Middle East & Africa Palbociclib Tablets Revenue by Country (2019-2024) 8.2 Middle East & Africa Palbociclib Tablets Sales by Type (2019-2024) 8.3 Middle East & Africa Palbociclib Tablets Sales by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Palbociclib Tablets 10.3 Manufacturing Process Analysis of Palbociclib Tablets 10.4 Industry Chain Structure of Palbociclib Tablets 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Palbociclib Tablets Distributors 11.3 Palbociclib Tablets Customer 12 World Forecast Review for Palbociclib Tablets by Geographic Region 12.1 Global Palbociclib Tablets Market Size Forecast by Region 12.1.1 Global Palbociclib Tablets Forecast by Region (2025-2030) 12.1.2 Global Palbociclib Tablets Annual Revenue Forecast by Region (2025-2030) 12.2 Americas Forecast by Country (2025-2030) 12.3 APAC Forecast by Region (2025-2030) 12.4 Europe Forecast by Country (2025-2030) 12.5 Middle East & Africa Forecast by Country (2025-2030) 12.6 Global Palbociclib Tablets Forecast by Type (2025-2030) 12.7 Global Palbociclib Tablets Forecast by Application (2025-2030) 13 Key Players Analysis 13.1 Pfizer 13.1.1 Pfizer Company Information 13.1.2 Pfizer Palbociclib Tablets Product Portfolios and Specifications 13.1.3 Pfizer Palbociclib Tablets Sales, Revenue, Price and Gross Margin (2019-2024) 13.1.4 Pfizer Main Business Overview 13.1.5 Pfizer Latest Developments 13.2 CSPC Ouyi Pharmaceutical 13.2.1 CSPC Ouyi Pharmaceutical Company Information 13.2.2 CSPC Ouyi Pharmaceutical Palbociclib Tablets Product Portfolios and Specifications 13.2.3 CSPC Ouyi Pharmaceutical Palbociclib Tablets Sales, Revenue, Price and Gross Margin (2019-2024) 13.2.4 CSPC Ouyi Pharmaceutical Main Business Overview 13.2.5 CSPC Ouyi Pharmaceutical Latest Developments 13.3 Zydus Lifesciences 13.3.1 Zydus Lifesciences Company Information 13.3.2 Zydus Lifesciences Palbociclib Tablets Product Portfolios and Specifications 13.3.3 Zydus Lifesciences Palbociclib Tablets Sales, Revenue, Price and Gross Margin (2019-2024) 13.3.4 Zydus Lifesciences Main Business Overview 13.3.5 Zydus Lifesciences Latest Developments 13.4 Synthon Pharmaceuticals 13.4.1 Synthon Pharmaceuticals Company Information 13.4.2 Synthon Pharmaceuticals Palbociclib Tablets Product Portfolios and Specifications 13.4.3 Synthon Pharmaceuticals Palbociclib Tablets Sales, Revenue, Price and Gross Margin (2019-2024) 13.4.4 Synthon Pharmaceuticals Main Business Overview 13.4.5 Synthon Pharmaceuticals Latest Developments 13.5 Sun Pharmaceutical 13.5.1 Sun Pharmaceutical Company Information 13.5.2 Sun Pharmaceutical Palbociclib Tablets Product Portfolios and Specifications 13.5.3 Sun Pharmaceutical Palbociclib Tablets Sales, Revenue, Price and Gross Margin (2019-2024) 13.5.4 Sun Pharmaceutical Main Business Overview 13.5.5 Sun Pharmaceutical Latest Developments 13.6 MSN Pharmaceuticals 13.6.1 MSN Pharmaceuticals Company Information 13.6.2 MSN Pharmaceuticals Palbociclib Tablets Product Portfolios and Specifications 13.6.3 MSN Pharmaceuticals Palbociclib Tablets Sales, Revenue, Price and Gross Margin (2019-2024) 13.6.4 MSN Pharmaceuticals Main Business Overview 13.6.5 MSN Pharmaceuticals Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
LP Information社の医薬品・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(tablets)の最新刊レポートよくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |